The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: A cross-sectional analysis

Osteoporosis International

Volumn 22, Issue 5, 2011, Pages 1431-1439

  Arends, S ^a   Spoorenberg, A ^b   Bruyn, G A W ^b   Houtman, P M ^b   Leijsma, M K ^a   Kallenberg, C G M ^a   Brouwer, E ^a   Van Der Veer, E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Ankylosing Spondylitis; Bone mineral density; Bone turnover markers; Inflammation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN TYPE 1 N TERMINAL PEPTIDE; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGE; ANKYLOSING SPONDYLITIS; ARTICLE; ASAS ENDORSED DISEASE ACTIVITY SCORE; BATH AS DISEASE ACTIVITY INDEX; BATH AS FUNCTIONAL INDEX; BONE DENSITY; BONE TURNOVER; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENDER; HIP; HUMAN; INFLAMMATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; FEMALE; HIP JOINT; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDES; RISK FACTORS; SPINAL FRACTURES; SPONDYLITIS, ANKYLOSING; VITAMIN D;

EID: 79955463371     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1338-7     Document Type: Article

References (36)

1. C Cooper L Carbone CJ Michet, et al. 1994 Fracture risk in patients with ankylosing spondylitis: a population based study J Rheumatol 21 10 1877 1882 7837154 1:STN:280:DyaK2M7jvV2ntw%3D%3D (Pubitemid 24312651)
2. D Vosse R Landewe D van der Heijde, et al. 2009 Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study Ann Rheum Dis 68 12 1839 1842 19066179 10.1136/ard.2008. 100503 1:STN:280:DC%2BD1MjlsFKhsA%3D%3D
3. P Geusens D Vosse S van der Linden 2007 Osteoporosis and vertebral fractures in ankylosing spondylitis Curr Opin Rheumatol 19 4 335 339 17551362 10.1097/BOR.0b013e328133f5b3 (Pubitemid 46884187)
4. H Franck T Meurer LC Hofbauer 2004 Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis J Rheumatol 31 11 2236 2241 15517638 1:CAS:528:DC%2BD2cXhtVCksLvN (Pubitemid 39453245)
5. I Ghozlani M Ghazi A Nouijai, et al. 2009 Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis Bone 44 5 772 776 19442629 10.1016/j.bone.2008.12.028 1:STN:280: DC%2BD1MzkvFKisA%3D%3D
6. J Gratacos A Collado F Pons, et al. 1999 Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study Arthritis Rheum 42 11 2319 2324 10555026 10.1002/1529-0131(199911)42:11<2319::AID- ANR9>3.0.CO;2-G 1:STN:280:DC%2BD3c%2FitFCqtQ%3D%3D (Pubitemid 30333411)
7. U Lange J Teichmann J Strunk, et al. 2005 Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis Osteoporos Int 16 12 1999 2004 16172800 10.1007/s00198-005-1990-5 1:CAS:528:DC%2BD2MXhtlWkt73F (Pubitemid 41790919)
8. JF Maillefert LS Aho A El Maghraoui, et al. 2001 Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study Osteoporos Int 12 7 605 609 11527060 10.1007/s001980170084 1:STN:280:DC%2BD3MvosFanuw%3D%3D (Pubitemid 32777439)
9. E Toussirot S Ricard-Blum G Dumoulin, et al. 1999 Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis Rheumatology 38 1 21 27 10334678 10.1093/rheumatology/38. 1.21 1:STN:280:DyaK1M3msFyntQ%3D%3D (Pubitemid 29509652)
10. A El Maghraoui 2004 Osteoporosis and ankylosing spondylitis Joint Bone Spine 71 4 291 295 15288853 10.1016/j.jbspin.2003.06.002 (Pubitemid 39037316)
11. U Lange O Jung J Teichmann, et al. 2001 Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis Osteoporos Int 12 12 1031 1035 11846329 10.1007/s001980170013 1:CAS:528:DC%2BD38XhsVWntbY%3D (Pubitemid 34105974)
12. B Mermerci Baskan Y Pekin Dogan F Sivas, et al. 2009 The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis Rheumatol Int 10.1007/s00296-009-0975-7 19685057
13. BM Obermayer-Pietsch U Lange G Tauber, et al. 2003 Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis Osteoporos Int 14 12 995 1000 14530911 10.1007/s00198-003-1501-5 1:CAS:528:DC%2BD3sXpvVCms70%3D (Pubitemid 40824267)
14. P Borman H Bodur N Bingol, et al. 2001 Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: relationship to disease activity J Clin Rheumatol 7 5 315 321 17039162 10.1097/00124743-200110000-00011 1:STN:280:DC%2BD2svgtVyksA%3D%3D (Pubitemid 32977729)
15. MC Park SJ Chung YB Park, et al. 2008 Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis Yonsei Med J 49 2 288 294 18452267 10.3349/ymj.2008.49.2.288 1:CAS:528:DC%2BD1cXmvVSntbc%3D (Pubitemid 351781179)
16. R Eastell RA Hannon 2008 Biomarkers of bone health and osteoporosis risk Proc Nutr Soc 67 2 157 162 18412989 10.1017/S002966510800699X (Pubitemid 351543397)
17. A El Maghraoui S Tellal S Chaouir, et al. 2005 Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis Clin Rheumatol 24 4 346 351 15592691 10.1007/s10067-004-1039-8 (Pubitemid 41102431)
18. K Karberg J Zochling J Sieper, et al. 2005 Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes J Rheumatol 32 7 1290 1298 15996067 (Pubitemid 40995385)
19. S Sarikaya A Basaran Y Tekin, et al. 2007 Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis? J Clin Rheumatol 13 1 20 24 17278944 10.1097/01.rhu.0000255688.83037.42 (Pubitemid 46213838)
20. N Yilmaz J Ozaslan 2000 Biochemical bone turnover markers in patients with ankylosing spondylitis Clin Rheumatol 19 2 92 98 10791618 10.1007/s100670050024 1:STN:280:DC%2BD3c3ltVamtQ%3D%3D (Pubitemid 30236137)
21. D Vosse R Landewe P Garnero, et al. 2008 Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis Rheumatology 47 8 1219 1222 18539620 10.1093/rheumatology/ken148 1:STN:280:DC%2BD1cvlsVyiuw%3D%3D (Pubitemid 352038230)
22. JA Kanis EV McCloskey H Johansson, et al. 2008 A reference standard for the description of osteoporosis Bone 42 3 467 475 18180210 10.1016/j.bone.2007. 11.001 1:CAS:528:DC%2BD1cXitVOmtbk%3D
23. HJ Baek SW Kang YJ Lee, et al. 2005 Osteopenia in men with mild and severe ankylosing spondylitis Rheumatol Int 26 1 30 34 15480679 10.1007/s00296-004-0516-3 1:STN:280:DC%2BD2MrmvF2jsg%3D%3D (Pubitemid 41531511)
24. YS Lee T Schlotzhauer SM Ott, et al. 1997 Skeletal status of men with early and late ankylosing spondylitis Am J Med 103 3 233 241 9316556 10.1016/S0002-9343(97)00143-5 1:STN:280:DyaK2svmt1artA%3D%3D (Pubitemid 27413406)
25. ES Meirelles A Borelli OP Camargo 1999 Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss Clin Rheumatol 18 5 364 368 10524549 10.1007/s100670050120 1:STN:280:DyaK1Mvlt1Wrsg%3D%3D (Pubitemid 29479763)
26. U Lange A Kluge J Strunk, et al. 2005 Ankylosing spondylitis and bone mineral density-what is the ideal tool for measurement? Rheumatol Int 26 2 115 120 15538574 10.1007/s00296-004-0515-4 (Pubitemid 41779819)
27. R Bessant A Keat 2002 How should clinicians manage osteoporosis in ankylosing spondylitis? J Rheumatol 29 7 1511 1519 12136913 (Pubitemid 34755621)
28. S van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 4 361 368 6231933 10.1002/art.1780270401 (Pubitemid 14134775)
29. J Braun J Davis M Dougados, et al. 2006 First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis Ann Rheum Dis 65 3 316 320 16096329 10.1136/ard.2005. 040758 1:CAS:528:DC%2BD28XisFCjt7k%3D (Pubitemid 43268219)
30. S Garrett T Jenkinson LG Kennedy, et al. 1994 A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index J Rheumatol 21 12 2286 2291 7699630 1:STN:280: DyaK2M3htl2qsQ%3D%3D
31. C Lukas R Landewe J Sieper, et al. 2009 Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Ann Rheum Dis 68 1 18 24 18625618 10.1136/ard.2008.094870 1:STN:280: DC%2BD1M%2FhsFaqtQ%3D%3D
32. D van der Heijde E Lie TK Kvien, et al. 2009 ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Ann Rheum Dis 68 12 1811 1818 19060001 10.1136/ard.2008.100826
33. A Calin S Garrett H Whitelock, et al. 1994 A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index J Rheumatol 21 12 2281 2285 7699629 1:STN:280:DyaK2M3htl2qsA%3D%3D
34. JA Kanis 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group Osteoporos Int 4 6 368 381 7696835 10.1007/BF01622200 1:STN:280: DyaK2M3htVyktA%3D%3D
35. HK Genant CY Wu C van Kuijk, et al. 1993 Vertebral fracture assessment using a semiquantitative technique J Bone Miner Res 8 9 1137 1148 8237484 10.1002/jbmr.5650080915 1:STN:280:DyaK2c%2FlsFyhuw%3D%3D (Pubitemid 23261108)
36. EP Amento 1987 Vitamin D and the immune system Steroids 49 1-3 55 72 3331847 10.1016/0039-128X(87)90079-1 1:CAS:528:DyaL1cXhsVygtL0%3D (Pubitemid 18088689)